Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery (SREENSTAPH2)
Primary Purpose
Staphylococcal Infections
Status
Completed
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Staphylococcus aureus carriage
Sponsored by
About this trial
This is an interventional screening trial for Staphylococcal Infections focused on measuring staphylococcal infections, nasal carriage, nasal cavity, Staphylococcus aureus
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing otorhinolaryngologic surgery, unknown Staphylococcus aureus carriage state
- Patient affiliated to French Social Security
- Written consent
Exclusion Criteria:
- Antibiotherapy or infectious episode during the month prior enrollment
- coagulation disorder
- neoplasia of the nasal cavity
Sites / Locations
- CHU Saint-Etienne
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Patient undergoing otorhinolaryngologic surgery
Arm Description
Staphylococcus aureus carriage is measured in the vestibulum nasi and posterior nasal cavity. Posterior nasal cavity is measured during endoscopic procedure.
Outcomes
Primary Outcome Measures
number of patients with staphylococcus aureus carriage in the posterior nasal cavity
Secondary Outcome Measures
number of patients with staphylococcus aureus carriage in the vestibulum nasi
Full Information
NCT ID
NCT02595112
First Posted
November 2, 2015
Last Updated
January 26, 2018
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
1. Study Identification
Unique Protocol Identification Number
NCT02595112
Brief Title
Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery
Acronym
SREENSTAPH2
Official Title
Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery. A Monocentric Study
Study Type
Interventional
2. Study Status
Record Verification Date
December 2017
Overall Recruitment Status
Completed
Study Start Date
February 4, 2016 (Actual)
Primary Completion Date
September 4, 2017 (Actual)
Study Completion Date
September 5, 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire de Saint Etienne
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Staphylococcus aureus nasal carriage is a major risk factor of infection with this bacterium. Staphylococcus aureus colonization of the posterior nasal cavity is still misunderstood. This study is aimed at evaluating the relationship between Staphylococcus aureus strains colonizing the vestibulum nasi, the sphenoethmoidal recess and the nasopharynx.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Staphylococcal Infections
Keywords
staphylococcal infections, nasal carriage, nasal cavity, Staphylococcus aureus
7. Study Design
Primary Purpose
Screening
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
95 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Patient undergoing otorhinolaryngologic surgery
Arm Type
Experimental
Arm Description
Staphylococcus aureus carriage is measured in the vestibulum nasi and posterior nasal cavity. Posterior nasal cavity is measured during endoscopic procedure.
Intervention Type
Other
Intervention Name(s)
Staphylococcus aureus carriage
Intervention Description
Vestibulum nasi and posterior nasal cavity sampling with swabs and posterior nasal cavity sampling by endoscopic procedure during otorhinolaryngologic surgery
Primary Outcome Measure Information:
Title
number of patients with staphylococcus aureus carriage in the posterior nasal cavity
Time Frame
Day 1
Secondary Outcome Measure Information:
Title
number of patients with staphylococcus aureus carriage in the vestibulum nasi
Time Frame
Day 1
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing otorhinolaryngologic surgery, unknown Staphylococcus aureus carriage state
Patient affiliated to French Social Security
Written consent
Exclusion Criteria:
Antibiotherapy or infectious episode during the month prior enrollment
coagulation disorder
neoplasia of the nasal cavity
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Paul Verhoeven
Organizational Affiliation
CHU Saint-Etienne
Official's Role
Principal Investigator
Facility Information:
Facility Name
CHU Saint-Etienne
City
Saint-Etienne
ZIP/Postal Code
42055
Country
France
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Study of Staphylococcus Aureus Colonization of the Posterior Nasal Cavity in Patients Undergoing Otorhinolaryngologic Surgery
We'll reach out to this number within 24 hrs